drugset / Trial / NCT01486251

Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer

NCT01486251

NaSingle-groupOpen-label

Summary

The purpose of this study is to evaluate and quantify the dynamic modifications of tumor blood perfusion on axitinib therapy in patients with refractory mCRC for each dose of Axitinib.

Timeline

Start
2011-09
Primary completion
2013-04
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Axitinib Small molecule 10 mg Oral

Indications